Entry Point Capital, LLC Tyra Biosciences, Inc. Transaction History
Entry Point Capital, LLC
- $112 Billion
- Q1 2024
A detailed history of Entry Point Capital, LLC transactions in Tyra Biosciences, Inc. stock. As of the latest transaction made, Entry Point Capital, LLC holds 1,345 shares of TYRA stock, worth $28,218. This represents 0.02% of its overall portfolio holdings.
Number of Shares
1,345Holding current value
$28,218% of portfolio
0.02%Shares
1 transactions
Others Institutions Holding TYRA
# of Institutions
77Shares Held
32.4MCall Options Held
600Put Options Held
3.7K-
Boxer Capital, LLC San Diego, CA6.45MShares$135 Million5.5% of portfolio
-
Bvf Inc San Francisco, CA4.66MShares$97.8 Million2.29% of portfolio
-
Canaan Partners Xi LLC Menlo Park, CA4.41MShares$92.5 Million85.38% of portfolio
-
Nextech Invest Ag4.06MShares$85.1 Million12.44% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA1.99MShares$41.7 Million3.43% of portfolio
About Tyra Biosciences, Inc.
- Ticker TYRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,973,600
- Market Cap $881M
- Description
- Tyra Biosciences, Inc., a preclinical-stage biopharmaceutical company, focuses on developing therapies to overcome tumor resistance and enhance outcomes for patients with cancer. Its lead product candidate is TYRA-300, a selective inhibitor of fibroblast growth factor receptor (FGFR)3 for the treatment of muscle invasive bladder cancer. The comp...